vs
Red Violet, Inc.（RDVT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Red Violet, Inc.的1.5倍（$35.5M vs $23.4M），Red Violet, Inc.净利率更高（12.0% vs -304.2%，领先316.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 19.6%），Red Violet, Inc.自由现金流更多（$6.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 15.6%）
Red Violet, Inc.是一家专注于高级数据分析、风险缓释与身份验证解决方案的科技企业，服务覆盖执法、金融服务、保险、企业合规等多个领域，通过整合公开及专有数据集为客户提供可落地的决策参考洞察。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RDVT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$23.4M
营收增速更快
RXRX
高出662.2%
19.6%
净利率更高
RDVT
高出316.3%
-304.2%
自由现金流更多
RDVT
多$53.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
15.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.4M | $35.5M |
| 净利润 | $2.8M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 6.8% | -304.8% |
| 净利率 | 12.0% | -304.2% |
| 营收同比 | 19.6% | 681.7% |
| 净利润同比 | 226.2% | 39.6% |
| 每股收益（稀释后） | $0.20 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RDVTRXRX
| Q4 25 | $23.4M | $35.5M | ||
| Q3 25 | $23.1M | $5.2M | ||
| Q2 25 | $21.8M | $19.2M | ||
| Q1 25 | $22.0M | $14.7M | ||
| Q4 24 | $19.6M | $4.5M | ||
| Q3 24 | $19.1M | $26.1M | ||
| Q2 24 | $19.1M | $14.4M | ||
| Q1 24 | $17.5M | $13.8M |
净利润RDVTRXRX
| Q4 25 | $2.8M | $-108.1M | ||
| Q3 25 | $4.2M | $-162.3M | ||
| Q2 25 | $2.7M | $-171.9M | ||
| Q1 25 | $3.4M | $-202.5M | ||
| Q4 24 | $863.0K | $-178.9M | ||
| Q3 24 | $1.7M | $-95.8M | ||
| Q2 24 | $2.6M | $-97.5M | ||
| Q1 24 | $1.8M | $-91.4M |
毛利率RDVTRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率RDVTRXRX
| Q4 25 | 6.8% | -304.8% | ||
| Q3 25 | 19.8% | -3327.6% | ||
| Q2 25 | 12.6% | -916.8% | ||
| Q1 25 | 19.1% | -1297.9% | ||
| Q4 24 | 1.9% | -4042.4% | ||
| Q3 24 | 13.1% | -377.1% | ||
| Q2 24 | 16.1% | -697.4% | ||
| Q1 24 | 11.3% | -698.4% |
净利率RDVTRXRX
| Q4 25 | 12.0% | -304.2% | ||
| Q3 25 | 18.3% | -3135.3% | ||
| Q2 25 | 12.3% | -894.2% | ||
| Q1 25 | 15.6% | -1373.3% | ||
| Q4 24 | 4.4% | -3935.5% | ||
| Q3 24 | 9.0% | -367.5% | ||
| Q2 24 | 13.8% | -676.6% | ||
| Q1 24 | 10.2% | -662.4% |
每股收益（稀释后）RDVTRXRX
| Q4 25 | $0.20 | $-0.17 | ||
| Q3 25 | $0.29 | $-0.36 | ||
| Q2 25 | $0.18 | $-0.41 | ||
| Q1 25 | $0.24 | $-0.50 | ||
| Q4 24 | $0.06 | $-0.56 | ||
| Q3 24 | $0.12 | $-0.34 | ||
| Q2 24 | $0.19 | $-0.40 | ||
| Q1 24 | $0.13 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $43.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $100.9M | $1.1B |
| 总资产 | $112.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资RDVTRXRX
| Q4 25 | $43.6M | $743.3M | ||
| Q3 25 | $45.4M | $659.8M | ||
| Q2 25 | $38.8M | $525.1M | ||
| Q1 25 | $34.6M | $500.5M | ||
| Q4 24 | $36.5M | $594.4M | ||
| Q3 24 | $35.7M | $427.6M | ||
| Q2 24 | $30.9M | $474.3M | ||
| Q1 24 | $32.1M | $296.3M |
总债务RDVTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益RDVTRXRX
| Q4 25 | $100.9M | $1.1B | ||
| Q3 25 | $101.7M | $1.0B | ||
| Q2 25 | $96.2M | $919.1M | ||
| Q1 25 | $91.8M | $933.9M | ||
| Q4 24 | $86.6M | $1.0B | ||
| Q3 24 | $91.7M | $524.6M | ||
| Q2 24 | $88.0M | $584.4M | ||
| Q1 24 | $83.8M | $401.2M |
总资产RDVTRXRX
| Q4 25 | $112.0M | $1.5B | ||
| Q3 25 | $112.1M | $1.4B | ||
| Q2 25 | $104.8M | $1.3B | ||
| Q1 25 | $99.1M | $1.3B | ||
| Q4 24 | $98.5M | $1.4B | ||
| Q3 24 | $98.0M | $726.5M | ||
| Q2 24 | $93.5M | $775.9M | ||
| Q1 24 | $94.0M | $557.8M |
负债/权益比RDVTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $6.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 28.1% | -133.1% |
| 资本支出强度资本支出/营收 | 0.5% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.38× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流RDVTRXRX
| Q4 25 | $6.7M | $-46.1M | ||
| Q3 25 | $10.2M | $-117.4M | ||
| Q2 25 | $7.5M | $-76.4M | ||
| Q1 25 | $5.0M | $-132.0M | ||
| Q4 24 | $6.7M | $-115.4M | ||
| Q3 24 | $7.2M | $-59.2M | ||
| Q2 24 | $5.7M | $-82.2M | ||
| Q1 24 | $4.3M | $-102.3M |
自由现金流RDVTRXRX
| Q4 25 | $6.6M | $-47.3M | ||
| Q3 25 | $10.0M | $-117.6M | ||
| Q2 25 | $7.3M | $-79.6M | ||
| Q1 25 | $5.0M | $-133.8M | ||
| Q4 24 | $6.7M | $-116.7M | ||
| Q3 24 | $7.2M | $-63.8M | ||
| Q2 24 | $5.7M | $-83.4M | ||
| Q1 24 | $4.2M | $-109.0M |
自由现金流率RDVTRXRX
| Q4 25 | 28.1% | -133.1% | ||
| Q3 25 | 43.3% | -2272.5% | ||
| Q2 25 | 33.5% | -413.9% | ||
| Q1 25 | 22.5% | -907.4% | ||
| Q4 24 | 34.1% | -2567.7% | ||
| Q3 24 | 37.8% | -244.6% | ||
| Q2 24 | 29.7% | -578.5% | ||
| Q1 24 | 24.2% | -789.9% |
资本支出强度RDVTRXRX
| Q4 25 | 0.5% | 3.5% | ||
| Q3 25 | 0.8% | 4.7% | ||
| Q2 25 | 0.9% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 0.4% | 48.2% |
现金转化率RDVTRXRX
| Q4 25 | 2.38× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.79× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 7.75× | — | ||
| Q3 24 | 4.22× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 2.41× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
